EUVIMEDEUVIMED entdecken
Open Access

Development of population pharmacokinetic models of total and free piperacillin in critically ill children and young adults for Monte Carlo simulations and model-informed precision dosing

Sonya Tang Girdwood iD, H Rhodes Hambrick, Ronaldo Morales Junior, Nieko Punt, Peter Tang, Calise Curry, Patrick Lahni, Rhonda Jones, Erin Stoneman, Abigayle Gibson, Jennifer Kaplan

Journal of Antimicrobial Chemotherapy · 2026

DOI: 10.1093/jac/dkaf423 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2026. Verfasst von Sonya Tang Girdwood und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Translational and Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Piperacillin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, Gerber Foundation Novice Research Award, NICHD Pediatric Clinical Pharmacology Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

We sought to develop population pharmacokinetic (PopPK) models of total and free piperacillin in critically ill children and young adults. We investigated the impact of kidney function and injury biomarkers and the effect of time on pharmacokinetic (PK) parameters.

Methods

We enrolled patients admitted to a paediatric ICU and prescribed piperacillin/tazobactam. We collected residual blood from clinical samples for total and free piperacillin concentrations. PopPK models were developed using nonlinear mixed effects modelling. Specific covariates of interest included time after antibiotic initiation, using a 48 h threshold, and urine neutrophil gelatinase-associated lipocalin (uNGAL), a tubular injury biomarker. Monte Carlo simulations investigated target attainment using different dosing regimens.

Results

Total (n = 695) and free concentrations (n = 639) from 139 patients were best described by two-compartment models. Creatinine-based estimated glomerular filtration rate (eGFR), uNGAL, and time >48 h after initial dosing were significant covariates of both total and free piperacillin clearance. Regarding central volume, albumin and cumulative fluid balance were significant covariates on total and free piperacillin, respectively. Simulations showed a common regimen of 100 mg/kg piperacillin/tazobactam every 6 h over a 30 min infusion is only sufficient for targeting bacteria with MICs of 2 mg/L or less in patients >30 kg with eGFR <150 mL/min/1.73 m2 or <30 kg with eGFR <90 mL/min/1.73 m2.

Conclusion

Using a large sample of critically ill children, we developed total and free piperacillin population PK models and newly identified uNGAL and time as significant covariates on piperacillin clearance. These models may be used for model-informed precision dosing after external validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsPiperacillinHumansCritical IllnessMonte Carlo MethodChildFemaleMaleChild, PreschoolYoung AdultAdolescentInfantPiperacillin, Tazobactam Drug Combination

Substanzen

Anti-Bacterial AgentsPiperacillinPiperacillin, Tazobactam Drug Combination

Autor:innen und Institutionen

  • Division of Translational and Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Division of Hospital Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
  • Division of Nephrology, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
  • Department of Pediatrics, Northwestern Feinberg School of Medicine, Chicago, IL, USA.
  • Medimatics, Maastricht, The Netherlands.

ORCID-Profile: Sonya Tang Girdwood

Förderung

  • NICHD NIH HHS
  • Gerber Foundation Novice Research Award
  • NICHD Pediatric Clinical Pharmacology Fellowship
  • Cincinnati Children's Hospital Medical Center (CCHMC) Hospital Medicine Fellow Award
  • NIGMS R35
  • CCHMC Arnold Strauss Fellow Award
  • NIGMS NIH HHS
  • Cincinnati Children’s Hospital Medical Center (CCHMC) Hospital Medicine Fellow Award

Zitieren

APA

Tang Girdwood, S., Hambrick, H. R., Morales Junior, R., Punt, N., Tang, P., Curry, C., Lahni, P., Jones, R., Stoneman, E., Gibson, A., & Kaplan, J. (2026). Development of population pharmacokinetic models of total and free piperacillin in critically ill children and young adults for Monte Carlo simulations and model-informed precision dosing. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf423

Vancouver

Tang Girdwood S, Hambrick HR, Morales Junior R, Punt N, Tang P, Curry C, et al. Development of population pharmacokinetic models of total and free piperacillin in critically ill children and young adults for Monte Carlo simulations and model-informed precision dosing. Journal of Antimicrobial Chemotherapy. 2026. doi:10.1093/jac/dkaf423

BibTeX
@article{TangGirdwood2026,
  author = {Tang Girdwood, Sonya and Hambrick, H Rhodes and Morales Junior, Ronaldo and Punt, Nieko and Tang, Peter and Curry, Calise and Lahni, Patrick and Jones, Rhonda and Stoneman, Erin and Gibson, Abigayle and Kaplan, Jennifer},
  title = {Development of population pharmacokinetic models of total and free piperacillin in critically ill children and young adults for Monte Carlo simulations and model-informed precision dosing},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2026},
  doi = {10.1093/jac/dkaf423}
}
Kostenlos starten →